Furthermore, no significant association was observed between FGFR1 amplification and clinical characteristics (age, gender, smoking status, lymph node metastasis, tumor stage, or brain metastasis) (Table 2). The gene discussed is FGFR1; the disease is metastatic malignant neoplasm in the lymph nodes.